CAM-H2 Patient Case Study e-Poster presented at EANM 2024

Our clinical team, lead by Precirix COO, Josie Gayton, along with study Investigators from CHUM - Centre hospitalier de l'Université de Montréal, put together a patient case study: "HER2+ breast cancer patient with brain metastasis, treated in a phase 1/2 study with the HER2-directed radiopharmaceutical, CAM-H2".

CAM-H2 Patient Case Study Poster - EANM